From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation. (Q30361595)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24751614%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

title

From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24751614%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24751614%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Martin Pal

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24751614%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Mark A Febbraio

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24751614%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

publication date

11 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24751614%20AND%20SRC:MED&resulttype=core&format=json

Immunology & Cell Biology

14 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24751614%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24751614%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

331-339

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24751614%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24751614%20AND%20SRC:MED&resulttype=core&format=json

Immunometabolism: an emerging frontier

14 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Lifetime risk and projected population prevalence of diabetes

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Muscles, exercise and obesity: skeletal muscle as a secretory organ

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Muscle as an endocrine organ: focus on muscle-derived interleukin-6.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Obesity promotes liver carcinogenesis via Mcl-1 stabilization independent of IL-6Rα signaling

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

The suppressors of cytokine signaling (SOCS) proteins: important feedback inhibitors of cytokine action.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Differences in wound healing in mice with deficiency of IL-6 versus IL-6 receptor.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Directing transition from innate to acquired immunity: defining a role for IL-6.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

IL-6 switches the differentiation of monocytes from dendritic cells to macrophages

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Imbalanced gp130-dependent signaling in macrophages alters macrophage colony-stimulating factor responsiveness via regulation of c-fms expression

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Transgenic blockade of interleukin 6 transsignaling abrogates inflammation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

The pro- and anti-inflammatory properties of the cytokine interleukin-6.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

The two faces of IL-6 on Th1/Th2 differentiation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Elevated IL-6 expression in CD4 T cells via PKCtheta and NF-kappaB induces Th2 cytokine production

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Transforming growth factor-beta induces development of the T(H)17 lineage

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

TGF-beta promotes Th17 cell development through inhibition of SOCS3.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Cutting Edge: Trans-Signaling via the Soluble IL-6R Abrogates the Induction of FoxP3 in Naive CD4+CD25- T Cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

How obesity causes diabetes: not a tall tale

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Raised interleukin-6 levels in obese patients.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

The role of interleukins in insulin resistance and type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

The anti-CD20 antibody rituximab reduces the Th17 cell response

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Interleukin-6 induces cellular insulin resistance in hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Interleukin-6 depletion selectively improves hepatic insulin action in obesity

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Structure and function of a new STAT-induced STAT inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPARalpha and UCP2 expression in rats

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Interleukin-6-deficient mice develop mature-onset obesity

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Astrocyte-specific deficiency of interleukin-6 and its receptor reveal specific roles in survival, body weight and behavior.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Brown adipose tissue regulates glucose homeostasis and insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Transgenic mice with astrocyte-targeted production of interleukin-6 are resistant to high-fat diet-induced increases in body weight and body fat.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Human IL6 enhances leptin action in mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Anti-IL-6 antibody treatment but not IL-6 knockout improves intestinal barrier function and reduces inflammation after binge ethanol exposure and burn injury

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-alpha levels after prolonged running.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Contraction and AICAR stimulate IL-6 vesicle depletion from skeletal muscle fibers in vivo

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Signaling Specificity of Interleukin-6 Action on Glucose and Lipid Metabolism in Skeletal Muscle

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

IL-6 is not essential for exercise-induced increases in glucose uptake.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Interleukin-6 mediates exercise-induced increase in insulin sensitivity in mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides and Staphyloccous aureus in human monocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Contraction-induced interleukin-6 gene transcription in skeletal muscle is regulated by c-Jun terminal kinase/activator protein-1

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Lipopolysaccharide and proinflammatory cytokines stimulate interleukin-6 expression in C2C12 myoblasts: role of the Jun NH2-terminal kinase

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

A stress signaling pathway in adipose tissue regulates hepatic insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Exercise stimulates c-Jun NH2 kinase activity and c-Jun transcriptional activity in human skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

The JNK signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

The role of JNK proteins in metabolism

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

A central role for JNK in obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Alteration of JNK-1 signaling in skeletal muscle fails to affect glucose homeostasis and obesity-associated insulin resistance in mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Muscle cells challenged with saturated fatty acids mount an autonomous inflammatory response that activates macrophages

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Targeting gp130 to prevent inflammation and promote insulin action.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

SOCS proteins: negative regulators of cytokine signaling

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Interleukin-6 modifies mRNA expression in mouse skeletal muscle.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

IL-6 is not necessary for the regulation of adipose tissue mitochondrial content

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.16

7 January 2021

Identifiers

DOI

10.1038/ICB.2014.16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24751614%20AND%20SRC:MED&resulttype=core&format=json

release_rwlewrm7ojdqxpjknsiuz347me

14 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rwlewrm7ojdqxpjknsiuz347me

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24751614%20AND%20SRC:MED&resulttype=core&format=json